Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
In the deal, Roche is adding CT-388, a Phase-2 ready, weekly-administered dual GLP-1/GIP receptor agonist for treating obesity in patients with and without type 2 diabetes
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 24 mg for weight management: A randomised, controlled, phase 1b trial
Continue reading Understanding the Two-Week Wait: How to Cope with Anxiety After IVF Sep 02, 2025 For many people going through IVF, the two weeks between embryo transfer and the pregnancy
Unlike some more stable peptides, the triple receptor binding domains in retatrutide are sensitive to thermal stress
US$ 23.74
US$ 28.07
US$ 24.66
US$ 28.41
US$ 23.43
US$ 26.82
US$ 27.30
